Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Therapy
HAART increases risk of metabolic complications in HIV-1 infection
September 27th, 2004
Highly active antiretroviral therapy increases the risk of metabolic complications in HIV-1-infected patients. "The availability of highly active antiretroviral therapy (HAART) has resulted in dramatic declines in morbidity and mortality in patients infected with human immunodeficiency virus-1 (HIV-1). However, the success of HAART has been tempered by the recognition of adverse metabolic effects clearly associated with its use," researchers in the United States report. "These 'metabolic complications' include dyslipidemia, changes in body fat distribution, insulin resistance and glucose intolerance, metabolic bone disease, and lactic acidosis," P.L....
Source: Diabetes Week (2004-09-27)
|
